Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by CMCents2investson Jul 20, 2017 10:27pm

59 Views

Post# 26493519

RE:RE:Interesting ... seems to be the way it goes ...

no the jury is in and reached a verdict ... we are back with the same Vancouver firm for financing ... what does that say other than all their efforts to raise money elsewhere failed

Bullboard Posts

Odd Burger to add 40 locations in Florida